Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	14.68	28.35	5.62	12.26	21.32	28.72
Short-Term Investments	0.01	0.01	-	-	-	-
Cash & Short-Term Investments	14.69	28.37	5.62	12.26	21.32	28.72
Cash Growth	-52.79%	404.91%	-54.16%	-42.50%	-25.79%	-27.47%
Other Receivables	2.28	2.24	3.11	2.01	3.84	3.78
Receivables	2.28	2.24	3.11	2.01	3.84	3.78
Inventory	0.01	0	0	0.01	0.01	0.1
Other Current Assets	0.07	0.06	0.02	0	-	-
Total Current Assets	17.06	30.67	8.75	14.28	25.16	32.61
Property, Plant & Equipment	0.47	0.38	0.36	0.48	0.61	0.68
Other Intangible Assets	0.05	0.19	0.22	0.38	0.52	0.63
Long-Term Deferred Tax Assets	5.16	4.13	2.39	2.22	2.05	1.81
Long-Term Deferred Charges	117.76	109.03	98	89.51	75.32	59.62
Other Long-Term Assets	0.13	0.13	0.13	0.03	0.03	0.03
Total Assets	140.61	144.52	109.85	106.9	103.7	95.38

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.11	2.75	2.13	3.41	5.06	2.91
Accrued Expenses	0.48	0.64	0.58	0.6	0.54	1.24
Current Portion of Long-Term Debt	5.85	10.98	8.74	11.92	12.17	4.17
Current Portion of Leases	0.02	0.02	0.02	0.02	0.02	-
Other Current Liabilities	0.23	1.37	0.27	0.46	0.93	0.35
Total Current Liabilities	10.69	15.77	11.74	16.41	18.73	8.67
Long-Term Debt	4.93	6.75	7.42	6.28	10.27	13.35
Long-Term Leases	-	0.01	0.03	0.06	0.08	-
Pension & Post-Retirement Benefits	-	-	0.09	-	-	0.28
Long-Term Deferred Tax Liabilities	5.16	4.13	2.39	2.22	2.05	1.81
Other Long-Term Liabilities	0.14	0.02	-	0.15	-	-
Total Liabilities	20.91	26.68	21.67	25.13	31.13	24.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.99	3.99	3.29	3.06	2.78	2.65
Additional Paid-In Capital	132.16	132.16	100.71	92.38	79.69	73.96
Retained Earnings	-22.13	-20.76	-18.16	-15.62	-12.27	-8.04
Treasury Stock	-5.8	-5.81	-2.03	-0.55	-0.62	-0.69
Comprehensive Income & Other	11.48	8.27	4.36	2.51	3	3.38
Shareholders' Equity	119.7	117.85	88.17	81.77	72.57	71.26
Total Liabilities & Equity	140.61	144.52	109.85	106.9	103.7	95.38

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10.8	17.76	16.21	18.27	22.54	17.52
Net Cash (Debt)	3.89	10.61	-10.59	-6.02	-1.22	11.2
Net Cash Growth	-70.05%	-	-	-	-	-57.02%
Net Cash Per Share	0.05	0.14	-0.16	-0.10	-0.02	0.21
Filing Date Shares Outstanding	77.52	77.51	64.75	60.88	55.29	52.76
Total Common Shares Outstanding	77.52	77.51	64.75	60.88	55.29	52.76
Working Capital	6.37	14.9	-2.99	-2.14	6.43	23.93
Book Value Per Share	1.54	1.52	1.36	1.34	1.31	1.35
Tangible Book Value	119.65	117.66	87.95	81.39	72.05	70.63
Tangible Book Value Per Share	1.54	1.52	1.36	1.34	1.30	1.34
Machinery	1.67	1.66	1.62	1.62	1.64	1.6

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error